The press releases contained in this section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Medicis has no obligation to update any information contained in such press releases after the date of their issuance. For current information about the Company, please refer to our most recent public filings with the Securities and Exchange Commission.

Note that in November 2008 the Company restated its financial statements for the annual, transition and quarterly periods in fiscal years 2003 through 2007 and the first and second quarters of 2008, and, accordingly, filed an amended annual report on Form 10-K/A for the year ended December 31, 2007, and amended quarterly reports on Forms 10-Q/A for the quarters ended March 31, 2008, and June 30, 2008. Readers are cautioned to refer to the SEC filings associated with the Company's restatement for correct financial data.

Receive all Medicis press releases via email

View the Medicis Press Release Archive

2006 Press Releases
Keyword Search:  
Dec 29, 2006
Medicis to Present At Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 14, 2006
Medicis Declares Cash Dividend
Nov 13, 2006
Medicis to Present at Credit Suisse Healthcare Conference
Nov 8, 2006
Medicis Reports Third Quarter 2006 Financial Results
Nov 7, 2006
Medicis and Dow Pharmaceutical Sciences Announce FDA Approval of Ziana (Clindamycin Phosphate 1.2% and Tretinoin 0.025%) Gel
Nov 6, 2006
Medicis Announces Third Quarter 2006 Conference Call and Webcast
Nov 3, 2006
Medicis to Present At CIBC World Markets Healthcare Conference
Oct 6, 2006
Medicis to Host Conference Call and Webcast from ASPS
Sep 22, 2006
Medicis to Present at UBS Global Life Sciences Conference
Sep 14, 2006
Medicis Declares Cash Dividend
Sep 5, 2006
Medicis to Present At Thomas Weisel Partners Healthcare Conference
Aug 2, 2006
Medicis Reports Second Quarter 2006 Financial Results
Jul 31, 2006
Medicis Announces Second Quarter 2006 Conference Call and Webcast
Jul 12, 2006
Medicis Names Jason Hanson Executive Vice President and General Counsel
Jul 12, 2006
Medicis and Ipsen Decide to Focus Partnership for Reloxin Exclusively on United States, Canada and Japan
Jun 14, 2006
Medicis to Present at Wachovia Securities Equity Conference
Jun 14, 2006
Medicis Declares Cash Dividend
Jun 8, 2006
Medicis to Present at Goldman Sachs Global Healthcare Conference
May 9, 2006
Medicis Reports First Quarter 2006 Financial Results
May 8, 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
May 4, 2006
Medicis Announces First Quarter 2006 Conference Call and Webcast
Apr 28, 2006
Medicis to Present at Morgan Stanley 2006 Global Healthcare Unplugged Conference
Apr 27, 2006
Medicis to Present at Deutsche Bank 31st Annual Health Care Conference
Apr 12, 2006
Medicis Announces Two Patents Issued for LOPROX Gel
Mar 20, 2006
Medicis to Ring the Opening Bell of the NYSE
Mar 20, 2006
Reloxin Agreement Between Ipsen and Medicis Becomes Effective
Mar 15, 2006
Medicis Reports December 2005 Financial Results
Mar 15, 2006
Medicis Declares Cash Dividend
Mar 13, 2006
Ipsen to Grant Medicis Rights to Distribute and Promote Ipsen's Botulinum Toxin Product to the Aesthetic Market
Mar 10, 2006
Medicis Announces December 2005 Quarter-End Conference Call and Webcast
Mar 2, 2006
Medicis Announces FDA Approval of Broader Indication for VANOS
Feb 3, 2006
Medicis to Present at Merrill Lynch 17th Annual Global Pharmaceutical, Biotechnology & Medical Device Conference
Jan 6, 2006
Medicis to Present at 24th Annual JPMorgan Healthcare Conference
Jan 3, 2006
Medicis to Present at Morgan Stanley Pharmaceutical CEOs Unplugged Conference


© 1996-2010 Medicis Pharmaceutical Corp